Table 2.

Distribution of inappropriate colonoscopies according to EPAGE and EPAGE-II criteria by indications

Inappropriate indications	EPAGE I n (%)	95% CI	EPAGE II n (%)	95% CI
Iron deficiency anemia	4 (2.3)	0.07–4.57	1 (0.7)	0.0001–2.08
Hematochezia	35 (20.3)	14.33–26.36	2 (1.4)	0.0001–3.34
Lower abdominal pain	28 (16.2)	10.76–21.79	60 (42.2)	34.12–50.37
Change in bowel habits	1 (0.5)	0.0001–1.71	2 (1.4)	0.0001–3.34
Uncomplicated Diarrhea	23 (13.3)	8.28–18.45	2 (1.4)	0.0001–3.34
Evaluation of known Ulcerative colitis	22 (12.7)	7.79–17.78	20 (14.0)	8.36–19.80
Evaluation of known Crohn’s disease	14 (8.1)	4.05–12.22	12 (8.4)	3.87–13.02
Surveillance post polypectomy	34 (19.7)	13.81–25.71	39 (27.4)	20.12–34.80
Surveillance after curative intent resection of CRC	2 (1.1)	0.0001–2.76	1 (0.7)	0.0001–2.08
CRC screening	1 (0.5)	0.0001–1.71	1 (0.7)	0.0001–2.08
Other	8 (4.5)	1.50–7.79	2 (1.4)	0.0001–3.34
Total	172 (100)		142 (100)